Loading chat...
FL S0116
Bill
Status
Failed
3/14/2020
Primary Sponsor
Banking and Insurance
Click for details
AI Summary
- Caps monthly cost-sharing for prescription insulin drugs at $100 per 30-day supply for individual and group health insurance policies, regardless of insulin type or amount needed
- Applies the $100 monthly cap to health maintenance organization (HMO) contracts providing insulin drug coverage
- Requires health benefit plans covering small employers issued or renewed on or after January 1, 2021 to comply with the insulin cost-sharing cap
- Defines "prescription insulin drug" as a prescription containing insulin used to treat diabetes and prescribed as medically necessary by a treating physician
- Allows insurers and HMOs to reduce insured cost-sharing obligations below the $100 cap and authorizes the Financial Services Commission to adopt implementing rules
- Effective January 1, 2021
Legislative Description
Prescription Insulin Drugs
Last Action
Died in Appropriations Subcommittee on Agriculture, Environment, and General Government
3/14/2020
Committee Referrals
Appropriations Subcommittee on Agriculture, Environment, and General Government1/17/2020
Banking and Insurance8/16/2019
Full Bill Text
No bill text available